Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Hydrogen peroxide vapour treatment inactivates norovirus but has limited effect on post-treatment viral RNA levels.

Holmdahl T, Odenholt I, Riesbeck K, Medstrand P, Widell A.

Infect Dis (Lond). 2019 Jan 16:1-9. doi: 10.1080/23744235.2018.1546056. [Epub ahead of print]

PMID:
30646786
2.

Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.

Palm AA, Lemey P, Jansson M, Månsson F, Kvist A, Szojka Z, Biague A, da Silva ZJ, Rowland-Jones SL, Norrgren H, Esbjörnsson J, Medstrand P.

MBio. 2019 Jan 8;10(1). pii: e01245-18. doi: 10.1128/mBio.01245-18.

3.

Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau: a prospective open cohort study.

Esbjörnsson J, Månsson F, Kvist A, da Silva ZJ, Andersson S, Fenyö EM, Isberg PE, Biague AJ, Lindman J, Palm AA, Rowland-Jones SL, Jansson M, Medstrand P, Norrgren H; Sweden and Guinea-Bissau Cohort Research Group.

Lancet HIV. 2018 Nov 1. pii: S2352-3018(18)30254-6. doi: 10.1016/S2352-3018(18)30254-6. [Epub ahead of print]

PMID:
30392769
4.

Prevalence of HIV-1 pretreatment drug resistance among treatment naïve pregnant women in Bissau, Guinea Bissau.

Wilhelmson S, Månsson F, Lopatko Lindman J, Biai A, Esbjörnsson J, Norrgren H, Jansson M, Medstrand P; SWEGUB CORE group.

PLoS One. 2018 Oct 31;13(10):e0206406. doi: 10.1371/journal.pone.0206406. eCollection 2018.

5.

HIV-genetic diversity and drug resistance transmission clusters in Gondar, Northern Ethiopia, 2003-2013.

Arimide DA, Abebe A, Kebede Y, Adugna F, Tilahun T, Kassa D, Assefa Y, Balcha TT, Björkman P, Medstrand P.

PLoS One. 2018 Oct 10;13(10):e0205446. doi: 10.1371/journal.pone.0205446. eCollection 2018.

6.

Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): A Randomized Controlled Trial.

Jespersen S, Hønge BL, Krarup H, Medstrand P, Sørensen A, Medina C, Té DDS, Correira FG, Erikstrup C, Østergaard L, Wejse C, Laursen AL; Bissau HIV Cohort study group.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):386-393. doi: 10.1097/QAI.0000000000001820.

PMID:
30044302
7.

Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study.

Reepalu A, Balcha TT, Sturegård E, Medstrand P, Björkman P.

Open Forum Infect Dis. 2017 Oct 8;4(4):ofx219. doi: 10.1093/ofid/ofx219. eCollection 2017 Fall.

8.

Development of an algorithm for determination of the likelihood of virological failure in HIV-positive adults receiving antiretroviral therapy in decentralized care.

Reepalu A, Balcha TT, Skogmar S, Isberg PE, Medstrand P, Björkman P.

Glob Health Action. 2017;10(1):1371961. doi: 10.1080/16549716.2017.1371961.

9.

Genetic characterization of human immunodeficiency virus type 1 transmission in the Middle East and North Africa.

Sallam M, Şahin GÖ, Ingman M, Widell A, Esbjörnsson J, Medstrand P.

Heliyon. 2017 Jul 10;3(7):e00352. doi: 10.1016/j.heliyon.2017.e00352. eCollection 2017 Jul.

10.

Virological failure and all-cause mortality in HIV-positive adults with low-level viremia during antiretroviral treatment.

Elvstam O, Medstrand P, Yilmaz A, Isberg PE, Gisslén M, Björkman P.

PLoS One. 2017 Jul 6;12(7):e0180761. doi: 10.1371/journal.pone.0180761. eCollection 2017.

11.

Decreasing prevalence of transmitted drug resistance among ART-naive HIV-1-infected patients in Iceland, 1996-2012.

Sallam M, Şahin GÖ, Indriðason H, Esbjörnsson J, Löve A, Widell A, Gottfreðsson M, Medstrand P.

Infect Ecol Epidemiol. 2017 Jun 13;7(1):1328964. doi: 10.1080/20008686.2017.1328964. eCollection 2017.

12.

Molecular epidemiology of HIV-1 in Iceland: Early introductions, transmission dynamics and recent outbreaks among injection drug users.

Sallam M, Esbjörnsson J, Baldvinsdóttir G, Indriðason H, Björnsdóttir TB, Widell A, Gottfreðsson M, Löve A, Medstrand P.

Infect Genet Evol. 2017 Apr;49:157-163. doi: 10.1016/j.meegid.2017.01.004. Epub 2017 Jan 7.

PMID:
28082188
13.

HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries.

Esbjörnsson J, Mild M, Audelin A, Fonager J, Skar H, Bruun Jørgensen L, Liitsola K, Björkman P, Bratt G, Gisslén M, Sönnerborg A, Nielsen C; SPREAD/ESAR Programme, Medstrand P, Albert J.

Virus Evol. 2016 Apr 27;2(1):vew010. eCollection 2016 Jan.

14.

CD4+ T cells with an activated and exhausted phenotype distinguish immunodeficiency during aviremic HIV-2 infection.

Buggert M, Frederiksen J, Lund O, Betts MR, Biague A, Nielsen M, Tauriainen J, Norrgren H, Medstrand P, Karlsson AC, Jansson M; SWEGUB CORE group.

AIDS. 2016 Oct 23;30(16):2415-2426.

15.

Elevated levels of invariant natural killer T-cell and natural killer cell activation correlate with disease progression in HIV-1 and HIV-2 infections.

Bächle SM, Malone DF, Buggert M, Karlsson AC, Isberg PE, Biague AJ, Norrgren H, Medstrand P, Moll M, Sandberg JK, Jansson M; SWEGUB CORE group.

AIDS. 2016 Jul 17;30(11):1713-22. doi: 10.1097/QAD.0000000000001147.

16.

Hydrogen Peroxide Vapor Decontamination in a Patient Room Using Feline Calicivirus and Murine Norovirus as Surrogate Markers for Human Norovirus.

Holmdahl T, Walder M, Uzcátegui N, Odenholt I, Lanbeck P, Medstrand P, Widell A.

Infect Control Hosp Epidemiol. 2016 May;37(5):561-6. doi: 10.1017/ice.2016.15. Epub 2016 Feb 10.

PMID:
26861195
17.

Cocirculation of several similar but unique HIV-1 recombinant forms in Guinea-Bissau revealed by near full-length genomic sequencing.

Palm AA, Esbjörnsson J, Månsson F, Biague A, da Silva ZJ, Norrgren H, Jansson M, Medstrand P.

AIDS Res Hum Retroviruses. 2015 Sep;31(9):938-45. doi: 10.1089/AID.2015.0073. Epub 2015 Jul 16.

PMID:
26066756
18.

High rates of virological suppression in a cohort of human immunodeficiency virus-positive adults receiving antiretroviral therapy in ethiopian health centers irrespective of concomitant tuberculosis.

Reepalu A, Balcha TT, Skogmar S, Jemal ZH, Sturegård E, Medstrand P, Björkman P.

Open Forum Infect Dis. 2014 Jun 19;1(1):ofu039. doi: 10.1093/ofid/ofu039. eCollection 2014 Mar.

19.

High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis.

Reepalu A, Balcha TT, Skogmar S, Jemal ZH, Sturegård E, Medstrand P, Björkman P.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19612. doi: 10.7448/IAS.17.4.19612. eCollection 2014.

20.

Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

AIDS. 2014 Apr 24;28(7):949-57.

PMID:
24812673
21.

Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: design and characterization of the enzymatic properties.

Shadrina O, Krotova O, Agapkina J, Knyazhanskaya E, Korolev S, Starodubova E, Viklund A, Lukashov V, Magnani M, Medstrand P, Karpov V, Gottikh M, Isaguliants M.

Biochimie. 2014 Jul;102:92-101. doi: 10.1016/j.biochi.2014.02.013. Epub 2014 Mar 2.

PMID:
24594066
22.

Effect of HIV-2 infection on HIV-1 disease progression and mortality.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

AIDS. 2014 Feb 20;28(4):614-5. doi: 10.1097/QAD.0000000000000142. No abstract available.

PMID:
24469002
23.

The origin and emergence of an HIV-1 epidemic: from introduction to endemicity.

Bruhn CA, Audelin AM, Helleberg M, Bjorn-Mortensen K, Obel N, Gerstoft J, Nielsen C, Melbye M, Medstrand P, Gilbert MT, Esbjörnsson J.

AIDS. 2014 Apr 24;28(7):1031-40. doi: 10.1097/QAD.0000000000000198.

PMID:
24451158
24.

Faster progression to AIDS and AIDS-related death among seroincident individuals infected with recombinant HIV-1 A3/CRF02_AG compared with sub-subtype A3.

Palm AA, Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Biague A, da Silva ZJ, Jansson M, Norrgren H, Medstrand P.

J Infect Dis. 2014 Mar 1;209(5):721-8. doi: 10.1093/infdis/jit416. Epub 2013 Aug 9.

PMID:
23935204
25.

Short-term HIV-1 treatment interruption is associated with dysregulated TLR-stimuli responsiveness.

Nowroozalizadeh S, Gudmundsdotter L, Hejdeman B, Andersson L, Esbjörnsson J, Medstrand P, Sandström E, Gaines H, Wahren B, Jansson M.

Hum Vaccin Immunother. 2013 Oct;9(10):2103-10. doi: 10.4161/hv.25154. Epub 2013 Jun 4.

26.

High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch.

Mild M, Gray RR, Kvist A, Lemey P, Goodenow MM, Fenyö EM, Albert J, Salemi M, Esbjörnsson J, Medstrand P.

Infect Genet Evol. 2013 Oct;19:369-77. doi: 10.1016/j.meegid.2013.05.004. Epub 2013 May 11.

PMID:
23672855
27.

Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection.

Özkaya Şahin G, Månsson F, Palm AA, Vincic E, da Silva Z, Medstrand P, Norrgren H, Fenyö EM, Jansson M.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):470-8. doi: 10.1089/AID.2012.0219. Epub 2012 Nov 21.

28.

Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.

Esbjörnsson J, Månsson F, Kvist A, Isberg PE, Nowroozalizadeh S, Biague AJ, da Silva ZJ, Jansson M, Fenyö EM, Norrgren H, Medstrand P.

N Engl J Med. 2012 Jul 19;367(3):224-32. doi: 10.1056/NEJMoa1113244.

29.

Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.

Karlsson U, Antonsson L, Ljungberg B, Medstrand P, Esbjörnsson J, Jansson M, Gisslen M.

AIDS. 2012 Sep 10;26(14):1739-44. doi: 10.1097/QAD.0b013e3283560791.

PMID:
22695299
30.

Increase of β-lactam-resistant invasive Haemophilus influenzae in Sweden, 1997 to 2010.

Resman F, Ristovski M, Forsgren A, Kaijser B, Kronvall G, Medstrand P, Melander E, Odenholt I, Riesbeck K.

Antimicrob Agents Chemother. 2012 Aug;56(8):4408-15. doi: 10.1128/AAC.00415-12. Epub 2012 Jun 11.

31.

Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.

Fenyö EM, Esbjörnsson J, Medstrand P, Jansson M.

J Intern Med. 2011 Dec;270(6):520-31. doi: 10.1111/j.1365-2796.2011.02455.x. Epub 2011 Oct 27.

32.

Copy number variation of the gene NCF1 is associated with rheumatoid arthritis.

Olsson LM, Nerstedt A, Lindqvist AK, Johansson SC, Medstrand P, Olofsson P, Holmdahl R.

Antioxid Redox Signal. 2012 Jan 1;16(1):71-8. doi: 10.1089/ars.2011.4013. Epub 2011 Aug 23.

PMID:
21728841
33.

HIV-1 molecular epidemiology in Guinea-Bissau, West Africa: origin, demography and migrations.

Esbjörnsson J, Mild M, Månsson F, Norrgren H, Medstrand P.

PLoS One. 2011 Feb 18;6(2):e17025. doi: 10.1371/journal.pone.0017025.

34.

Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa.

Esbjörnsson J, Månsson F, Martínez-Arias W, Vincic E, Biague AJ, da Silva ZJ, Fenyö EM, Norrgren H, Medstrand P.

Retrovirology. 2010 Mar 22;7:23. doi: 10.1186/1742-4690-7-23.

35.

Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.

Karlsson U, Antonsson L, Repits J, Medstrand P, Owman C, Kidd-Ljunggren K, Hagberg L, Svennerholm B, Jansson M, Gisslén M, Ljungberg B.

AIDS Res Hum Retroviruses. 2009 Dec;25(12):1297-1305. doi: 10.1089/aid.2009.0069.

36.

The non-coding RNA of the multidrug resistance-linked vault particle encodes multiple regulatory small RNAs.

Persson H, Kvist A, Vallon-Christersson J, Medstrand P, Borg A, Rovira C.

Nat Cell Biol. 2009 Oct;11(10):1268-71. doi: 10.1038/ncb1972. Epub 2009 Sep 13.

PMID:
19749744
37.

Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.

Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.

Infect Genet Evol. 2010 Apr;10(3):356-64. doi: 10.1016/j.meegid.2009.05.003. Epub 2009 May 14.

PMID:
19446658
38.

Non-coding antisense transcription detected by conventional and single-stranded cDNA microarray.

Vallon-Christersson J, Staaf J, Kvist A, Medstrand P, Borg A, Rovira C.

BMC Genomics. 2007 Aug 29;8:295.

39.

Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination.

Flockerzi A, Maydt J, Frank O, Ruggieri A, Maldener E, Seifarth W, Medstrand P, Lengauer T, Meyerhans A, Leib-Mösch C, Meese E, Mayer J.

Retrovirology. 2007 Jun 6;4:39.

40.

Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.

Mild M, Esbjörnsson J, Fenyö EM, Medstrand P.

J Virol. 2007 Apr;81(7):3369-76. Epub 2007 Jan 24.

41.

Multiple effects govern endogenous retrovirus survival patterns in human gene introns.

van de Lagemaat LN, Medstrand P, Mager DL.

Genome Biol. 2006;7(9):R86.

42.

Isolation of human immunodeficiency virus-type 1 (HIV-1) clones with biological and molecular properties of the primary isolate.

Mild M, Björndal A, Medstrand P, Fenyö EM.

Virology. 2006 Jun 20;350(1):58-66. Epub 2006 Mar 24.

43.

Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies.

Hansson SR, Chen Y, Brodszki J, Chen M, Hernandez-Andrade E, Inman JM, Kozhich OA, Larsson I, Marsál K, Medstrand P, Xiang CC, Brownstein MJ.

Mol Hum Reprod. 2006 Mar;12(3):169-79. Epub 2006 Mar 23.

PMID:
16556680
44.

Up-regulation and increased phosphorylation of protein kinase C (PKC) delta, mu and theta in the degenerating rd1 mouse retina.

Azadi S, Paquet-Durand F, Medstrand P, van Veen T, Ekström PA.

Mol Cell Neurosci. 2006 Apr;31(4):759-73. Epub 2006 Feb 28.

PMID:
16503160
45.

Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency.

Repits J, Oberg M, Esbjörnsson J, Medstrand P, Karlsson A, Albert J, Fenyö EM, Jansson M.

J Gen Virol. 2005 Oct;86(Pt 10):2859-69.

PMID:
16186242
46.

Genomic deletions and precise removal of transposable elements mediated by short identical DNA segments in primates.

van de Lagemaat LN, Gagnier L, Medstrand P, Mager DL.

Genome Res. 2005 Sep;15(9):1243-9.

47.

Impact of transposable elements on the evolution of mammalian gene regulation.

Medstrand P, van de Lagemaat LN, Dunn CA, Landry JR, Svenback D, Mager DL.

Cytogenet Genome Res. 2005;110(1-4):342-52. Review.

PMID:
16093686
48.

Promoter usage of BRCA1-IRIS.

Kvist A, Rovira C, Borg A, Medstrand P.

Nat Cell Biol. 2005 Apr;7(4):325-6; author rply 326. No abstract available.

PMID:
15803125
49.
50.

Transposable elements in mammals promote regulatory variation and diversification of genes with specialized functions.

van de Lagemaat LN, Landry JR, Mager DL, Medstrand P.

Trends Genet. 2003 Oct;19(10):530-6.

PMID:
14550626

Supplemental Content

Loading ...
Support Center